Existing literature suggests that GIPC2 interacts with Frizzled receptors in the WNT signaling pathway, a known regulator of CRC progression, and may also influence the PI3K/AKT pathway, which regulates cell survival and migration (33). This evidence concerns the gene GIPC2 and colorectal carcinoma.